Seattle Genetics
Padcev
Manufacturer:
Seattle Genetics
Name:
Padcev
HCPCS Code Descriptor:
Injection, enfortumab vedotin-ejfv, 0.25 mg
Category:
J Code
HCPCS:
J9177
NDC(s):
51144-0030-01, 51144-0020-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
Padcev is an Oncology drug manufactured by Seattle Genetics and administered via the Intravenous route of administration. The J Code: J9177 is aligned to the drug Padcev.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/20
HCPCS Effective Date:
7/1/20
HCPCS Short Description:
Inj enfort vedo-ejfv 0.25mg
Billing and Coding Guide:
https://astellaspharmasupportsolutions.com/docs/padcev/PADCEV_Coding_Billing_Guide.pdf
Patient Assistance:
https://astellaspharmasupportsolutions.com/patient/padcev/index.aspx